Australia Orthopedic Biomaterials Market Report, 2020-2026 – Market Trends & Developments, Procedure Numbers, Competitive Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite” report has been added to ResearchAndMarkets.com’s offering.

The orthopedic biomaterials market includes bone graft substitutes, HA viscosupplementation and growth factors.

In 2019, the largest segment was the orthopedic bone graft substitute market, which includes allografts, DBM allografts and synthetics. In Australia, synthetics are the most popular material for orthopedic bone graft substitute procedures, largely due to a limited supply of allografts and DBM allografts.

The report includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. The report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation.

Key Topics Covered

1. Executive Summary
2. Australian Orthopedic Biomaterials Market Overview
3. Competitive Analysis
4. Market Trends
5. Market Developments
6. Procedure Numbers
7. Markets Included
8. Key Report Updates

Product Assessment

• Introduction
• Product Portfolios
• Regulatory Issues and Recalls
• Clinical Trials

Australian Orthopedic Biomaterials Market Overview

• Introduction
• Currency Exchange Rate
• Market Overview and Trend Analysis
• Drivers and Limiters
• Competitive Market Share Analysis
• Mergers and Acquisitions
• Company Profiles
• SWOT Analysis

Procedure Numbers

• Introduction
• Procedures

Orthopedic Bone Graft Substitute Market

• Introduction
• Market Overview
• Market Analysis and Forecast
• Drivers and Limiters
• Competitive Market Share Analysis

Orthopedic Growth Factor Market

• Introduction
• Market Analysis and Forecast
• Drivers and Limiters
• Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

• Introduction
• Market Overview
• Market Analysis and Forecast
• Drivers and Limiters
• Competitive Market Share Analysis

Companies Mentioned

• Alphatec
• Medacta
• Anika Therapeutics
• Medical + Optical
• Arthrex
• Medtronic
• Australian Biotechnologies
• New South Wales Bone Bank
• Australian Tissue Donation Network
• NovaBone
• B. Braun
• NuVasive
• Barwon Health Bone Bank
• Orthotech
• Baxter
• OsteoMed
• Biocomposites
• Perth Bone and Tissue Bank
• Bioventus
• Precision Surgical
• Cerapedics
• Prism Surgical
• Corin
• Pureplay Orthopaedics
• DePuy Synthes
• Queensland Tissue Bank
• Donor Tissue Bank of Victoria
• Rachel Forster Bone Bank
• Finceramica
• Sanofi
• Globus Medical
• Signature Spine and Joint
• Hunter New England and Local Health District
• SIGNUS Medical
• Hunter New England Bone Bank
• Smith & Nephew
• Institute of Medical & Veterinary Science
• South Eastern Sydney Local Health District
• Joy Surgical
• Stryker
• JRI Orthopaedics – Tecres
• Kasios
• The Queensland Bone Bank
• LifeHealthcare
• Wright Medical
• LMT Surgical
• Zimmer Biomet

For more information about this report visit https://www.researchandmarkets.com/r/1g49u3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900